Novo Nordisk has just announced that their drug liraglutide is extremely effective at inducing weight loss among people suffering from type 2 diabetes. In a 56-week long double-blind phase 3a clinical trial, part of the SCALETM (Satiety and Clinical Adiposity Liraglutide Evidence in Non-diabetic and Diabetic people) program, researchers identified the effectiveness of liraglutide 3 mg as an obesity treatment. Liraglutide 3 mg is a GLP-1 analogue taken once a day...
More...
More...